Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas. [electronic resource] by
- Pishvaian, Michael
- Morse, Michael A
- McDevitt, Jennifer
- Norton, Jonathan D
- Ren, Song
- Robbie, Gabriel J
- Ryan, Patricia C
- Soukharev, Serguei
- Bao, Haifeng
- Denlinger, Crystal S
Producer: 20171016
In:
Clinical colorectal cancer vol. 15
Availability: No items available.
|
|
|
15.
|
Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma. [electronic resource] by
- Parker, Joseph M
- Oh, Chad K
- LaForce, Craig
- Miller, S David
- Pearlman, David S
- Le, Chenxiong
- Robbie, Gabriel J
- White, Wendy I
- White, Barbara
- Molfino, Nestor A
Producer: 20110614
In:
BMC pulmonary medicine vol. 11
Availability: No items available.
|